1209 related articles for article (PubMed ID: 25952970)
1. Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment.
Arnold RS; Fedewa SA; Goodman M; Osunkoya AO; Kissick HT; Morrissey C; True LD; Petros JA
Bone; 2015 Sep; 78():81-6. PubMed ID: 25952970
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment.
Arnold RS; Sun CQ; Richards JC; Grigoriev G; Coleman IM; Nelson PS; Hsieh CL; Lee JK; Xu Z; Rogatko A; Osunkoya AO; Zayzafoon M; Chung L; Petros JA
Prostate; 2009 Jan; 69(1):1-11. PubMed ID: 18850577
[TBL] [Abstract][Full Text] [Related]
3. Tumour-based Mutational Profiles Predict Visceral Metastasis Outcome and Early Death in Prostate Cancer Patients.
Cussenot O; Timms KM; Perrot E; Blanchet P; Brureau L; Solimeno C; Fromont G; Comperat E; Cancel-Tassin G
Eur Urol Oncol; 2024 Jun; 7(3):597-604. PubMed ID: 38182487
[TBL] [Abstract][Full Text] [Related]
4. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
5. Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.
Ng CKY; Bidard FC; Piscuoglio S; Geyer FC; Lim RS; de Bruijn I; Shen R; Pareja F; Berman SH; Wang L; Pierga JY; Vincent-Salomon A; Viale A; Norton L; Sigal B; Weigelt B; Cottu P; Reis-Filho JS
Clin Cancer Res; 2017 Aug; 23(15):4402-4415. PubMed ID: 28351929
[No Abstract] [Full Text] [Related]
6. Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity.
Nordstrand A; Bovinder Ylitalo E; Thysell E; Jernberg E; Crnalic S; Widmark A; Bergh A; Lerner UH; Wikström P
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29670000
[TBL] [Abstract][Full Text] [Related]
7. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
[TBL] [Abstract][Full Text] [Related]
8. Characterization of bone metastases from rapid autopsies of prostate cancer patients.
Mehra R; Kumar-Sinha C; Shankar S; Lonigro RJ; Jing X; Philips NE; Siddiqui J; Han B; Cao X; Smith DC; Shah RB; Chinnaiyan AM; Pienta KJ
Clin Cancer Res; 2011 Jun; 17(12):3924-32. PubMed ID: 21555375
[TBL] [Abstract][Full Text] [Related]
9. Germline and somatic DNA repair gene alterations in prostate cancer.
Dall'Era MA; McPherson JD; Gao AC; DeVere White RW; Gregg JP; Lara PN
Cancer; 2020 Jul; 126(13):2980-2985. PubMed ID: 32315455
[TBL] [Abstract][Full Text] [Related]
10. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.
Cher ML; Bova GS; Moore DH; Small EJ; Carroll PR; Pin SS; Epstein JI; Isaacs WB; Jensen RH
Cancer Res; 1996 Jul; 56(13):3091-102. PubMed ID: 8674067
[TBL] [Abstract][Full Text] [Related]
11. Somatic mutations of the mitochondrial genome in human breast cancers.
Tseng LM; Yin PH; Yang CW; Tsai YF; Hsu CY; Chi CW; Lee HC
Genes Chromosomes Cancer; 2011 Oct; 50(10):800-11. PubMed ID: 21748819
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial DNA mutations in prostate cancer bone metastases.
Keith CG; Arnold RS; Petros JA
J Nat Sci; 2015 Aug; 1(8):. PubMed ID: 31728409
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial DNA mutations in pancreatic cancer.
Kassauei K; Habbe N; Mullendore ME; Karikari CA; Maitra A; Feldmann G
Int J Gastrointest Cancer; 2006; 37(2-3):57-64. PubMed ID: 17827523
[TBL] [Abstract][Full Text] [Related]
14. Somatic mutations of the mitochondrial genome in Chinese patients with Ewing sarcoma.
Yu M; Wan Y; Zou Q
Hum Pathol; 2013 Jul; 44(7):1350-6. PubMed ID: 23375644
[TBL] [Abstract][Full Text] [Related]
15. p53 mutations in prostate cancer bone metastases suggest that selected p53 mutants in the primary site define foci with metastatic potential.
Navone NM; Labate ME; Troncoso P; Pisters LL; Conti CJ; von Eschenbach AC; Logothetis CJ
J Urol; 1999 Jan; 161(1):304-8. PubMed ID: 10037428
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid.
Zhu W; Qin W; Bradley P; Wessel A; Puckett CL; Sauter ER
Carcinogenesis; 2005 Jan; 26(1):145-52. PubMed ID: 15375011
[TBL] [Abstract][Full Text] [Related]
17. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial DNA mutations in Malaysian female breast cancer patients.
Omasanggar R; Yu CY; Ang GY; Emran NA; Kitan N; Baghawi A; Falparado Ahmad A; Abdullah MA; Teh LK; Maniam S
PLoS One; 2020; 15(5):e0233461. PubMed ID: 32442190
[TBL] [Abstract][Full Text] [Related]
19. Association of p53 mutations with metastatic prostate cancer.
Eastham JA; Stapleton AM; Gousse AE; Timme TL; Yang G; Slawin KM; Wheeler TM; Scardino PT; Thompson TC
Clin Cancer Res; 1995 Oct; 1(10):1111-8. PubMed ID: 9815901
[TBL] [Abstract][Full Text] [Related]
20. Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases.
Stapleton AM; Timme TL; Gousse AE; Li QF; Tobon AA; Kattan MW; Slawin KM; Wheeler TM; Scardino PT; Thompson TC
Clin Cancer Res; 1997 Aug; 3(8):1389-97. PubMed ID: 9815823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
